Cargando…

Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study

BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Shiu-Dong, Lin, Ching-Chun, Wang, Li-Hsuan, Lin, Herng-Ching, Kang, Jiunn-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694900/
https://www.ncbi.nlm.nih.gov/pubmed/23826304
http://dx.doi.org/10.1371/journal.pone.0067459
_version_ 1782274911691079680
author Chung, Shiu-Dong
Lin, Ching-Chun
Wang, Li-Hsuan
Lin, Herng-Ching
Kang, Jiunn-Horng
author_facet Chung, Shiu-Dong
Lin, Ching-Chun
Wang, Li-Hsuan
Lin, Herng-Ching
Kang, Jiunn-Horng
author_sort Chung, Shiu-Dong
collection PubMed
description BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups. RESULTS: The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69–18.54) per 100 person-years; this was 24.35 (95% CI = 23.66–25.05) and 11.86 (95% CI = 11.39–12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73–1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05–2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37–29.38). CONCLUSIONS: We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries.
format Online
Article
Text
id pubmed-3694900
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36949002013-07-03 Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study Chung, Shiu-Dong Lin, Ching-Chun Wang, Li-Hsuan Lin, Herng-Ching Kang, Jiunn-Horng PLoS One Research Article BACKGROUND: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. METHODS: We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups. RESULTS: The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69–18.54) per 100 person-years; this was 24.35 (95% CI = 23.66–25.05) and 11.86 (95% CI = 11.39–12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73–1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05–2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37–29.38). CONCLUSIONS: We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries. Public Library of Science 2013-06-27 /pmc/articles/PMC3694900/ /pubmed/23826304 http://dx.doi.org/10.1371/journal.pone.0067459 Text en © 2013 Chung et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chung, Shiu-Dong
Lin, Ching-Chun
Wang, Li-Hsuan
Lin, Herng-Ching
Kang, Jiunn-Horng
Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title_full Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title_fullStr Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title_full_unstemmed Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title_short Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study
title_sort zolpidem use and the risk of injury: a population-based follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694900/
https://www.ncbi.nlm.nih.gov/pubmed/23826304
http://dx.doi.org/10.1371/journal.pone.0067459
work_keys_str_mv AT chungshiudong zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy
AT linchingchun zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy
AT wanglihsuan zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy
AT linherngching zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy
AT kangjiunnhorng zolpidemuseandtheriskofinjuryapopulationbasedfollowupstudy